NewGenIVF Group (NIVF)
Provides fertility treatment and referral services in Thailand, Cambodia, and Kyrgyzstan.
Something off on this page? Send us feedback.
Provides assisted-reproduction treatments through clinics in Thailand and Cambodia and earns referral commissions in Kyrgyzstan. Audited revenue remains tied to IVF and fertility referrals, while cell sorting, UAE real estate, digital assets, and prediction-market initiatives sit outside its reportable segments.
Operates assisted-reproduction clinics in Thailand and Cambodia, providing IVF/ICSI, embryo transfer, egg donation where permitted, genetic testing, and related laboratory services. Also earns commissions by referring customers to independent fertility and surrogacy agents in Kyrgyzstan; clients generally pay before service, and revenue is recognized when treatments conclude or referral commissions are received.
Owns MicroSort sperm-sorting technology and Nodexus cell-sorting assets, with a disclosed plan to lease devices to clinics and charge equipment and consumables fees. NewGenProperty's UAE venture and NewGenDigital's digital-asset and AI prediction-market activities sit outside the audited reportable segments, which remain IVF and fertility referrals. Clinical operations and expansion depend on licenses, cross-border patient access, and local partners.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Dec 31, 2025Cash & short-term investments $758.6K · Total debt $4.9M · Total assets $32.7M · Shareholders' equity $26.6M
- Revenue
- $1.4M
- Operating income
- −$5.0M
- Net income
- −$7.7M
No dividends on record.
| Institutions4 holders · as of Mar 31, 2026 | 0.29% | 190 shares | |
| Insiders3 holders · as of Sep 2, 2026 | — | 3.73M shares | |
| Strategic holders2 holders · as of Jun 8, 2026 | — | 2.0K shares |
institutions as of Mar 31, 2026 · holders as of their latest filing
No reliable share count is available for this listing, so stakes are shown as shares, not percentages.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
The institutional percentage is the one reported with the filings, not one recomputed on the share count here.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Kong Yiu CheungInsiderdirector, 10 percent owner | — | 3.72M | Form 4filed Sep 2, 2026 ↗ |
Hei Yue Tina Fong1Insiderdirector | — | 6,321 | Form 4filed Jun 5, 2026 ↗ |
Wing Fung Alfred SiuInsiderdirector | — | 6,320 | Form 4filed Jun 5, 2026 ↗ |
HRT Financial LPStrategic10 percent owner | — | 2,015 | Form 4filed Jun 8, 2026 ↗ |
Tower Research Capital LLC (TRC)Institution | — | 1,500 | 13Fas of Mar 31, 2026 |
| See all 13 → | |||
- Reported at 2.80% on Jun 8, 2026, under the 5% line, so no further filing is required.
13F — a manager's quarterly holdings · Form 4 — an insider's transaction report
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jul 27, 2026 | Kong Yiu Cheung | director, 10 percent owner: | +2,500,000 | $1.00 |
| Jun 18, 2026 | Kong Yiu Cheung | director, 10 percent owner: | +500,000 | $1.33 |
| Jun 2, 2026 | Kong Yiu Cheung | director, 10 percent owner: | +500,000 | $1.33 |
| May 28, 2026 | Kong Yiu Cheung | director, 10 percent owner: | +222,223 | $1.50 |
| Jun 4, 2026 | HRT Financial LP | 10 percent owner | −64,945 | $0.7810 |
